Encapsulation

Oracle Releases Java 17

Retrieved on: 
Tuesday, September 14, 2021
Cloud, Library, Project, MacOS, GPL, Metal (API), Java version history, D3 Security Management Systems, OCI, Ecosystem, ACORN (PRNG), Distributed object communication, 406, LTS, Encapsulation, AOT, Experiment, JNI, API, RMI, Language, CPU, Love, 306, Panama, JDK, Organization, JVM, IDC, Silicon, Java Platform, Standard Edition, Community, 414, JEP, Oracle Cloud, Second, Maintenance, Java, Semantics, JIT, Applet, Adoption, Software development, Apple, Bootstrapping (compilers), Java Native Interface, Environment, JDK Enhancement Proposal, GNU General Public License, Java Community Process, Apple-designed processors, JCP, Information technology, Coffee, Software, Video game, Satellite navigation device, Computer data storage

Java 17 is the latest long-term support (LTS)release under Java's six-month release cadence and is the result of extensive collaboration between Oracle engineers and other members of the worldwide Java developer community via the OpenJDK Community and the Java Community Process (JCP).

Key Points: 
  • Java 17 is the latest long-term support (LTS)release under Java's six-month release cadence and is the result of extensive collaboration between Oracle engineers and other members of the worldwide Java developer community via the OpenJDK Community and the Java Community Process (JCP).
  • Oracle will also continue providing Oracle OpenJDK releases under the open-source General Public License (GPL), as it has since 2017.
  • Backed by the Oracle LTS and Java SE Subscription, customers can migrate to Java 17 at the pace that best meets their needs.
  • To accelerate Java adoption in the cloud, Oracle recently introduced the Oracle Java Management Service , a new Oracle Cloud Infrastructure (OCI)-native service to help organizations manage Java runtimes and applications on-premises or on any cloud.

Automotive Engine Encapsulation Market by Material Type, Vehicle Class, and Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 19, 2020
Automotive, Other Automotive, Encapsulation

The "Automotive Engine Encapsulation Market - By Material Type, By Vehicle Class, and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automotive Engine Encapsulation Market - By Material Type, By Vehicle Class, and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global Automotive Engine Encapsulation market garnered earnings worth approximately 5 (USD Billion) in 2019 and is set to record a CAGR of over 7% the period from 2020 to 2026.
  • The report offers assessment and analysis of the Automotive Engine Encapsulation market on a global and regional level.
  • The global automotive engine encapsulation market is segmented as follows:

Electronic Board Level Underfill and Encapsulation Material Market is estimated to expand at a CAGR of 5.5% by during 2020-2030: PMR

Retrieved on: 
Monday, September 14, 2020
Computing, Encapsulation, Smartphone, Classes of computers, Computers

As such, the Global Electronic Board Level Underfill and Encapsulation Material Marketis estimated to expand at a CAGR of 5.5% by during the forecast period of 2020-2030.

Key Points: 
  • As such, the Global Electronic Board Level Underfill and Encapsulation Material Marketis estimated to expand at a CAGR of 5.5% by during the forecast period of 2020-2030.
  • Launch of new generation of smartphones will also drive the electronic board level underfill and encapsulation material market.
  • East Asia accounts for a nearly one-fourth share in the global electronic board level underfill and encapsulation material market.
  • The report provides in-depth analysis of the electronic board level underfill and encapsulation material market through different segments, namely, product type, material, board type, and region.

Food Encapsulation Market to hit $55 billion by 2026, Says Global Market Insights, Inc.

Retrieved on: 
Wednesday, July 29, 2020
Health, Articles, Pharmacology, Micro-encapsulation, Polymers, Nutraceutical, Capsule, Encapsulation

SELBYVILLE, Del., July 29, 2020 /PRNewswire/ -- Global food encapsulation market revenue is projected to cross USD 55 Billion by 2026, according to a new research report by Global Market Insights, Inc. High effectiveness of food encapsulation in delivering an adequate amount of ingredient, thereby improving the bioavailability of the material will drive food encapsulation industry growth.

Key Points: 
  • SELBYVILLE, Del., July 29, 2020 /PRNewswire/ -- Global food encapsulation market revenue is projected to cross USD 55 Billion by 2026, according to a new research report by Global Market Insights, Inc. High effectiveness of food encapsulation in delivering an adequate amount of ingredient, thereby improving the bioavailability of the material will drive food encapsulation industry growth.
  • Increasing investments in research & development towards new product launches with improved functional aspects is propelling the food encapsulation business growth.
  • Microencapsulation dominates the global food encapsulation market accounting for over 36% market share in 2019.
  • Some major findings of the global food encapsulation market report include:
    Positive outlook for the nutraceuticals industry accompanied by functional advantages of encapsulation will support the market growth.

Food Encapsulation Market to hit $55 billion by 2026, Says Global Market Insights, Inc.

Retrieved on: 
Wednesday, July 29, 2020
Health, Articles, Pharmacology, Micro-encapsulation, Polymers, Nutraceutical, Capsule, Encapsulation

SELBYVILLE, Del., July 29, 2020 /PRNewswire/ -- Global food encapsulation market revenue is projected to cross USD 55 Billion by 2026, according to a new research report by Global Market Insights, Inc. High effectiveness of food encapsulation in delivering an adequate amount of ingredient, thereby improving the bioavailability of the material will drive food encapsulation industry growth.

Key Points: 
  • SELBYVILLE, Del., July 29, 2020 /PRNewswire/ -- Global food encapsulation market revenue is projected to cross USD 55 Billion by 2026, according to a new research report by Global Market Insights, Inc. High effectiveness of food encapsulation in delivering an adequate amount of ingredient, thereby improving the bioavailability of the material will drive food encapsulation industry growth.
  • Increasing investments in research & development towards new product launches with improved functional aspects is propelling the food encapsulation business growth.
  • Microencapsulation dominates the global food encapsulation market accounting for over 36% market share in 2019.
  • Some major findings of the global food encapsulation market report include:
    Positive outlook for the nutraceuticals industry accompanied by functional advantages of encapsulation will support the market growth.

butter LONDON™ Expands its Nail Treatment Innovation Offering with the Launch of Jelly Preserve Nail Strengthening Treatment

Retrieved on: 
Wednesday, July 15, 2020
Cosmetics, Nail polish, Nail, Encapsulation, Jelly, Visual arts

ATLANTA, July 15, 2020 /PRNewswire-PRWeb/ --Today, butter LONDON announced the launch of its latest product: Jelly Preserve Strengthening Treatment.

Key Points: 
  • ATLANTA, July 15, 2020 /PRNewswire-PRWeb/ --Today, butter LONDON announced the launch of its latest product: Jelly Preserve Strengthening Treatment.
  • "Adding a protective encapsulation coating to the active ingredients in Jelly Preserve helps make the ingredients more gentle and effective.
  • Jelly Preserve Strengthening Treatment acts like a leave-in conditioner for the nails and truly takes 'nail polish' to the next level.
  • Jelly Preserve nail treatment is available in two, sheer nail shades and will retail at $18.

OLEO, Inc. Leads CBD Products Industry in Testing and Regulations

Retrieved on: 
Friday, February 14, 2020
Drugs, Encapsulation, Cannabidiol, Organ systems

In partnership with ProVerde Laboratories , OLEO has worked since 2016 to help develop rigorous analytical testing methods to ensure that CBD concentration is accurately measured and that the CBD products meet food safety protocol, as micro-encapsulation technology is known to require unique sample prep and analytical testing methods.

Key Points: 
  • In partnership with ProVerde Laboratories , OLEO has worked since 2016 to help develop rigorous analytical testing methods to ensure that CBD concentration is accurately measured and that the CBD products meet food safety protocol, as micro-encapsulation technology is known to require unique sample prep and analytical testing methods.
  • This micro-encapsulation technology ensures that OLEO's products and Powered by OLEO partner products offer double the bioaccessibility of regular CBD, meaning higher amounts of cannabidiol that can be absorbed by the body.
  • The micro-encapsulation process additionally removes any bitter aftertaste, allowing both the flavored and non-flavored drink mixes to taste better than regular CBD products.
  • We look forward to working with them to continue pushing the industry forward through test method standardization and the kind of rigorous testing protocol that is standard in all OLEO CBD products."

Dr. Raymond Labs Launches ZEROID, #1 Dermocosmetic in Korea in the United States

Retrieved on: 
Tuesday, October 22, 2019
Lamella, Materials science, Encapsulation

SAN FRANCISCO, Oct. 21, 2019 /PRNewswire/ -- Dr. Raymond Labs, a K-Beauty skincare company, announces the expansion of its top-selling dermocosmetic line into the United States.

Key Points: 
  • SAN FRANCISCO, Oct. 21, 2019 /PRNewswire/ -- Dr. Raymond Labs, a K-Beauty skincare company, announces the expansion of its top-selling dermocosmetic line into the United States.
  • For the last ten years, ZEROID has been the number one-selling dermocosmetic brand in Korea, mainly sold in hospitals under a doctor's recommendation.
  • Now, however, ZEROID is being made available for online purchase in the United States.
  • Dr. Raymond Labs has invented platform Skin Barrier Technology, named as Multi Lamella Emulsion and Crystal Lamella MES (Micro-Encapsulation System) and have published more than fifty articles covering dermatological research.

PharmaCyte Biotech Q&A Discussion with Cellular Biologist David A. Judd

Retrieved on: 
Tuesday, October 1, 2019
Research, Pharmaceutical, Oncology, Science, Clinical trials, Biotechnology, Stem cells, Health, Diabetes, RTT, Gastrointestinal cancer, Pancreatic cancer, Encapsulation

This interview-style Q&A article is with David A. Judd, a cellular biologist and a member of PharmaCytes Medical and Scientific Advisory Board.

Key Points: 
  • This interview-style Q&A article is with David A. Judd, a cellular biologist and a member of PharmaCytes Medical and Scientific Advisory Board.
  • David Judd: PharmaCytes approach is exceedingly unique in how it treats pancreatic cancer.
  • David Judd: Cell-in-a-Box is another encapsulation technology that is being evaluated in the market, but unique in its use of cellulose.
  • David Judd: Changes to a manufacturing process early on is standard; the process at Austrianova is no exception.

PharmaCyte Biotech Releases Results of Shareholder Meeting and Provides Information on Upcoming Shareholder Update Call

Retrieved on: 
Thursday, September 12, 2019
Medical devices, Diabetes, Stem cells, Biotechnology, Pharmaceutical, Health, Oncology, Shareholder, Stock market, Encapsulation

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box , today announced the results of the Special Shareholder Meeting and provides information on the shareholder update conference call scheduled for next week.

Key Points: 
  • PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box , today announced the results of the Special Shareholder Meeting and provides information on the shareholder update conference call scheduled for next week.
  • PharmaCytes Chief Executive Officer, Kenneth L. Waggoner, held a lengthy question and answer session with the shareholders who attended the meeting.
  • PharmaCyte has scheduled the upcoming shareholder update conference call for Friday, September 20, 2019, commencing at 4:00 p.m. Eastern Daylight Time to update all shareholders simultaneously in a public forum.
  • More information about PharmaCyte Biotech can be found at www.PharmaCyte.com .